Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 17, 2023 07:00 ET | Source: Forbion

enGene, Inc. and Forbion European Acquisition Corp. (“FEAC”, Nasdaq: FRBN) Announce Business Combination Agreement to Create Nasdaq-Listed Biotechnology Company Developing Next-Generation Non-Viral, Locally Administered Gene Therapies

Leading institutional investors commit $135 million USD in transaction financing, anchored by FEAC’s sponsor, Forbion Growth Sponsor FEAC I B.V. (together with its parent entity Forbion Growth...
May 04, 2023 08:59 ET | Source: Forbion

Forbion appoints Silva Deželan, PhD as Head of Impact and ESG

NAARDEN, Netherlands and MUNICH, Germany, May 04, 2023 (GLOBE NEWSWIRE) -- Forbion, a leading European life sciences venture capital firm, announces the appointment of Silva Deželan PhD, as...
April 19, 2023 01:00 ET | Source: Forbion

Forbion raises €1.35 billion across two funds

Forbion’s largest fundraising to date€750 million raised in the final close of the Forbion Ventures Fund VI €600 million raised in the final close of the Forbion Growth Opportunities Fund II Brings...
August 04, 2022 03:00 ET | Source: Forbion

Forbion Co-leads $70 Million Financing of F2G to Advance Development and Commercialization of New Antifungal Agent Olorofim

Forbion Co-leads $70 Million Financing of F2G to Advance Development and Commercialization of New Antifungal Agent Olorofim Naarden, The Netherlands, 4 August 2022 – Forbion, a leading European life...
July 20, 2022 02:00 ET | Source: Forbion

Forbion appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner

Forbion appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner Naarden, The Netherlands – 20 July 2022 – Forbion, a leading European life sciences venture...
June 09, 2022 02:00 ET | Source: Forbion

Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million

Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million New fund to invest in late-stage European life sciences companiesInvestors include Pantheon, pension funds PME...
September 14, 2021 02:00 ET | Source: BioGeneration Ventures

BGV Expands Team with the Appointment of a Partner and Venture Partner

BGV Expands Team with the Appointment of a Partner and Venture Partner Naarden, The Netherlands, 14 September 2021 – BioGeneration Ventures (“BGV”), a leading early-stage VC in European biopharma,...
September 01, 2021 03:00 ET | Source: Forbion

Forbion Appoints Nanna Lüneborg as a General Partner

Forbion Appoints Nanna Lüneborg as a General Partner - Brings extensive international investment and board experience in life sciences companies of all sizes including company creations, private...